Hyundai Motor Company Australia has been working in partnership with the Steven Walter Children’s Cancer Foundation for over five years, supporting research into a cure for childhood cancer. Together they have created a new ‘partnership in discovery’ by founding the Hyundai Help for Kids Cancer Research Project. This new joint initiative has been established to create a distinct research project focused on childhood cancer. 

As a young man aged 19 and living with cancer, Steven Walter wrote a powerful letter to his family and friends asking them to raise money for childhood cancer research “so that one day no other kid would have to go through what I’ve been through”. Since 2001 Steven Walter Children’s Cancer Foundation (SWCCF) has been instrumental in supporting clinical trials and research projects in its quest for 100% survival for all children diagnosed with cancer.

The Hyundai Help for Kids Cancer Research Project will be jointly undertaken at the Kids Cancer Centre (KCC) at Sydney Children’s Hospital and the Children’s Cancer Centre (CCC) at the Royal Children’s Hospital, Melbourne, both of which are at the forefront of paediatric oncology clinical research. Three leading childhood cancer researchers will focus on the discovery, development, and exposure of new treatments focused on children with cancer and leukaemia.

The project will target newly diagnosed patients as well as research treatments for patients who’ve relapsed. The project will also look at developing Personalised Cancer Care for High Risk Cancers, whereby treatment response in patients will be measured, monitored and managed in recognition that no two cancers are the same and require specific and personalised treatments.

Hyundai Help for Kids is honoured to partner with Steven Walter Children’s Cancer Foundation to create the Hyundai Help for Kids Cancer Research Project and to work together to achieve the goal of 100% survival for all children with cancer and the prevention of their suffering.

Hyundai Help for Kids joins the Steven Walter Children’s Cancer Foundation as proud Naming Rights Partner of this clinical trial, providing monetary funding to help facilitate research initiatives, as well as vehicle fleet support.